Free Trial

scPharmaceuticals (SCPH) SEC Filings & 10K Form

scPharmaceuticals logo
$5.57 -0.01 (-0.18%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$5.57 0.00 (0.00%)
As of 09/5/2025 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent scPharmaceuticals SEC Filings

DateFilerForm TypeView
08/25/2025
3:20 PM
MANNKIND CORP (Filed by)
scPharmaceuticals (Subject)
Form SC TO-C
08/25/2025
3:15 PM
scPharmaceuticals (Subject)
Form SC14D9C
08/25/2025
7:46 AM
MANNKIND CORP (Filed by)
scPharmaceuticals (Subject)
Form SC TO-C
08/25/2025
6:33 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2025
6:35 AM
scPharmaceuticals (Subject)
Form SC14D9C
08/25/2025
5:02 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
4:31 PM
Agger Mette Kirstine (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:48 PM
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:49 PM
Bonstein Sara (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:59 PM
Baylor-Henry Minnie (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
3:18 PM
scPharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/21/2025
3:12 PM
scPharmaceuticals (Filer)
Form DEFA14A
03/19/2025
4:27 PM
scPharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/19/2025
4:20 PM
scPharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
3:27 PM
Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
9:56 AM
KING LUTHER CAPITAL MANAGEMENT CORP (Filed by)
scPharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/10/2025
7:01 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:30 PM
scPharmaceuticals (Issuer)
Tucker John H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
5:04 AM
scPharmaceuticals (Filer)
Form 10-Q/A
12/11/2024
5:30 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:48 PM
Lundbeckfond Invest A/S (Filed by)
scPharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
4:16 PM
scPharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SCPH) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners